BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24348245)

  • 1. CRISPR-Cas immunity against phages: its effects on the evolution and survival of bacterial pathogens.
    Marraffini LA
    PLoS Pathog; 2013; 9(12):e1003765. PubMed ID: 24348245
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-CRISPR proteins: Counterattack of phages on bacterial defense (CRISPR/Cas) system.
    Chaudhary K; Chattopadhyay A; Pratap D
    J Cell Physiol; 2018 Jan; 233(1):57-59. PubMed ID: 28247934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of CRISPR-mediated microbial immunity.
    Gasiunas G; Sinkunas T; Siksnys V
    Cell Mol Life Sci; 2014 Feb; 71(3):449-65. PubMed ID: 23959171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs.
    Borges AL; Davidson AR; Bondy-Denomy J
    Annu Rev Virol; 2017 Sep; 4(1):37-59. PubMed ID: 28749735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins.
    Bondy-Denomy J; Garcia B; Strum S; Du M; Rollins MF; Hidalgo-Reyes Y; Wiedenheft B; Maxwell KL; Davidson AR
    Nature; 2015 Oct; 526(7571):136-9. PubMed ID: 26416740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Holding a grudge: persisting anti-phage CRISPR immunity in multiple human gut microbiomes.
    Mick E; Stern A; Sorek R
    RNA Biol; 2013 May; 10(5):900-6. PubMed ID: 23439321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of molecular mechanisms used by anti-CRISPR proteins: the tip of an iceberg?
    Hardouin P; Goulet A
    Biochem Soc Trans; 2020 Apr; 48(2):507-516. PubMed ID: 32196554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CRISPR-Cas systems by mobile genetic elements.
    Sontheimer EJ; Davidson AR
    Curr Opin Microbiol; 2017 Jun; 37():120-127. PubMed ID: 28668720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CRISPR: discovery, mechanism and function.
    Pawluk A; Davidson AR; Maxwell KL
    Nat Rev Microbiol; 2018 Jan; 16(1):12-17. PubMed ID: 29062071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria.
    Yosef I; Manor M; Kiro R; Qimron U
    Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7267-72. PubMed ID: 26060300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical modelling of CRISPR-Cas system effects on biofilm formation.
    Ali Q; Wahl LM
    J Biol Dyn; 2017 Aug; 11(sup2):264-284. PubMed ID: 28426329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR--a widespread system that provides acquired resistance against phages in bacteria and archaea.
    Sorek R; Kunin V; Hugenholtz P
    Nat Rev Microbiol; 2008 Mar; 6(3):181-6. PubMed ID: 18157154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling and enhancing CRISPR systems.
    Shivram H; Cress BF; Knott GJ; Doudna JA
    Nat Chem Biol; 2021 Jan; 17(1):10-19. PubMed ID: 33328654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasty viruses, costly plasmids, population dynamics, and the conditions for establishing and maintaining CRISPR-mediated adaptive immunity in bacteria.
    Levin BR
    PLoS Genet; 2010 Oct; 6(10):e1001171. PubMed ID: 21060859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five big mysteries about CRISPR's origins.
    Ledford H
    Nature; 2017 Jan; 541(7637):280-282. PubMed ID: 28102279
    [No Abstract]   [Full Text] [Related]  

  • 16. Revenge of the phages: defeating bacterial defences.
    Samson JE; Magadán AH; Sabri M; Moineau S
    Nat Rev Microbiol; 2013 Oct; 11(10):675-87. PubMed ID: 23979432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost and benefits of clustered regularly interspaced short palindromic repeats spacer acquisition.
    Bradde S; Mora T; Walczak AM
    Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180095. PubMed ID: 30905281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering and shaping bacterial diversity through CRISPR.
    Briner AE; Barrangou R
    Curr Opin Microbiol; 2016 Jun; 31():101-108. PubMed ID: 27045713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A jumbo phage that forms a nucleus-like structure evades CRISPR-Cas DNA targeting but is vulnerable to type III RNA-based immunity.
    Malone LM; Warring SL; Jackson SA; Warnecke C; Gardner PP; Gumy LF; Fineran PC
    Nat Microbiol; 2020 Jan; 5(1):48-55. PubMed ID: 31819217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Biology of CRISPR-Cas: Backward and Forward.
    Hille F; Richter H; Wong SP; Bratovič M; Ressel S; Charpentier E
    Cell; 2018 Mar; 172(6):1239-1259. PubMed ID: 29522745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.